• DOI:10.1016/j.rmed.2012.09.014
Corpus ID: 24474519

Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD.

@article{Bjermer2013LocalAS,
  title={Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD.},
  author={L. Bjermer and T. Bengtsson and C. Jorup and J. L{\"o}tvall},
  journal={Respiratory medicine},
  year={2013},
  volume={107 1},
  pages={
          84-90
        }
}

L. Bjermer, T. Bengtsson, +1 author J. Lötvall

Published 2013

Medicine

Respiratory medicine

There is still a need for new agents which improve upon the therapeutic index of tiotropium, the current standard of care for many patients with chronic obstructive pulmonary disease (COPD). We examined in patients with COPD the efficacy of single doses of AZD9164, an M(3)-selective muscarinic antagonist, to identify an appropriate dose-range for future studies. COPD patients (n = 28) inhaled AZD9164 (100, 400 and 1200 μg), tiotropium (18 μg) and placebo at 5 study centre visits (Clinicaltrials… CONTINUE READING

View on PubMed

resmedjournal.com

Save to Library

Create Alert

Cite

Launch Research Feed